Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Protontherapy: basis, indications and new technologies].
Mazal A, Habrand JL, Delacroix S, Datchary J, Dendale R, Desjardins L, Ferrand R, Malka V, Fourquet A. Mazal A, et al. Among authors: habrand jl. Bull Cancer. 2010 Jul;97(7):831-46. doi: 10.1684/bdc.2010.1149. Bull Cancer. 2010. PMID: 20603240 French.
[Chordomas of the base of the skull and upper cervical spine. 100 patients irradiated by a 3D conformal technique combining photon and proton beams].
Noël G, Feuvret L, Dhermain F, Mammar H, Haie-Méder C, Ponvert D, Hasboun D, Ferrand R, Nauraye C, Boisserie G, Beaudré A, Gaboriaud G, Mazal A, Touboul E, Habrand JL, Mazeron JJ. Noël G, et al. Among authors: habrand jl. Cancer Radiother. 2005 May;9(3):161-74. doi: 10.1016/j.canrad.2005.04.005. Cancer Radiother. 2005. PMID: 15979920 Clinical Trial. French.
[Optic neuropathy after proton-beam therapy for malignant choroidal melanoma].
Meyer A, Lévy C, Blondel J, D'hermies F, Frau E, Schlienger P, Mammar H, Delacroix S, Nauraye C, Desblancs C, Ferrand R, Mazal A, Asselain B, Plancher C, Habrand J, Desjardins L. Meyer A, et al. J Fr Ophtalmol. 2000 Jun;23(6):543-53. J Fr Ophtalmol. 2000. PMID: 10880919 French.
[Which equipment for proton therapy of the future?].
Schwartz LH, Laisne A, Ivanov AA, Mandrillon P, Chauvel P, Mazal A, Habrand JL, Tronc D, Baccal M, Laugier A, et al. Schwartz LH, et al. Among authors: habrand jl. Bull Cancer Radiother. 1995;82(4):365-9. Bull Cancer Radiother. 1995. PMID: 8554889 French.
Clinical applications of proton therapy.
Habrand JL, Schlienger P, Schwartz L, Pontvert D, Lenir-Cohen-Solal C, Helfre S, Mammar H, Haie-Meder C, Ferrand R, Mazal A. Habrand JL, et al. Bull Cancer Radiother. 1996;83 Suppl:207s-11s. doi: 10.1016/0924-4212(96)84914-0. Bull Cancer Radiother. 1996. PMID: 8949781
[Protontherapy: physical and technical basis].
Mazal A, Delacroix S, Arianer J, Clapier F, Nauraye C, Louis M, Rosenwald JC, Bridier A, Habrand JL. Mazal A, et al. Among authors: habrand jl. Bull Cancer Radiother. 1996;83(4):230-46. Bull Cancer Radiother. 1996. PMID: 9081321 Review. French. No abstract available.
[Protontherapy. Clinical features].
Habrand JL, Desjardins L, Mammar H, Mazal A. Habrand JL, et al. Bull Cancer Radiother. 1996;83(4):247-53. Bull Cancer Radiother. 1996. PMID: 9081322 Review. French. No abstract available.
175 results